Skip to main content
. 2022 Nov 14;14(22):5573. doi: 10.3390/cancers14225573

Table 2.

Association of immune-related molecules with therapy method and response.

Variables Therapy Method p Tumor Regression Grade p
nCT nCRT TRG 0 TRG 1 TRG 2 TRG 3
CTLA-4+ cells Low 54 (50.9) 75 (50.3) 0.924 26 (52.0) 45 (55.6) 42 (51.2) 16 (38.1) 0.324
High 52 (49.1) 74 (49.7) 24 (48.0) 36 (44.4) 40 (48.8) 26 (61.9)
CD86+ cells Low 85 (80.2) 134 (89.9) 0.028 * 47 (94.0) 72 (88.9) 67 (81.7) 33 (78.6) 0.096
High 21 (19.8) 15 (10.1) 3 (6.0) 9 (11.1) 15 (18.3) 15 (21.4)
tCD4+ cells Low 85 (88.5) 106 (97.2) 0.014 * 0 79 (97.5) 77 (93.9) 35 (83.3) 0.012 *
High 11 (11.5) 3 (2.8) 0 2 (2.5) 5 (6.1) 7 (16.7)
NA 10 40 50 0 0 0
sCD4+ cells Low 41 (38.7) 85 (57.0) 0.004 * 31 (62.0) 45 (55.6) 37 (45.1) 13 (31.0) 0.013 *
High 65 (61.3) 64 (43.0) 19 (38.0) 36 (44.4) 45 (54.9) 29 (69.0)
iCD4+ cells Low 52 (49.1) 115 (77.2) 0.000 * 44 (88.0) 61 (75.3) 44 (53.7) 18 (42.9) 0.000 *
High 54 (50.9) 34 (22.8) 6 (12.0) 20 (24.7) 38 (46.3) 24 (57.1)
tCD8+ cells Low 58 (60.4) 90 (82.6) 0.000 * 0 64 (79.0) 58 (70.7) 26 (61.9) 0.124
High 38 (39.6) 19 (17.4) 0 17 (21.0) 24 (29.3) 16 (38.1)
NA 10 40 50 0 0 0
sCD8+ cells Low 51 (48.1) 80 (53.7) 0.380 33 (66.0) 40 (49.4) 35 (42.7) 23 (54.8) 0.069
High 55 (51.9) 69 (46.3) 17 (34.0) 41 (50.6) 47 (57.3) 19 (45.2)
iCD8+ cells Low 79 (74.5) 131 (87.9) 0.006 * 50 (100.0) 67 (82.7) 61 (74.4) 32 (76.2) 0.002 *
High 27 (25.5) 18 (12.1) 0 (0.0) 14 (17.3) 21 (25.6) 10 (23.8)
TRG TRG 0 10 (9.4) 40 (26.8) 0.000 * - - - - -
TRG 1 24 (22.6) 57 (38.3) - - - -
TRG 2 35 (33.0) 47 (31.5) - - - -
TRG 3 37 (34.9) 5 (3.4) - - - -

*, p < 0.05, statistically significant; the p value of 0.000 indicated p < 0.001.